Allergic contact dermatitis to triethanolamine in a child

Nicola Milanesi1, Samantha Berti2, Massimo Gola1

  • 1Allergological and Occupational Dermatology Unit, University of Florence, Florence, Italy.

Pediatric Dermatology
|March 18, 2015
PubMed

Insights

Contact dermatitis to triethanolamine in cosmetics is rare in children. Patch testing is crucial for diagnosis, even in young patients, to identify specific allergens.

Area of Science:

  • Dermatology
  • Allergology
  • Cosmetic Science

Background:

  • Triethanolamine is a common emulsifier in cosmetics and topical medications.
  • Contact dermatitis to triethanolamine is infrequently reported, especially in pediatric populations.

Observation:

  • A case of a child presenting with suspected contact dermatitis to a cosmetic product is described.
  • The rarity of childhood reactions to triethanolamine prompted a thorough diagnostic investigation.

Findings:

  • Patch testing confirmed triethanolamine as the causative allergen.
  • This case underscores that young age does not preclude allergic contact dermatitis to common cosmetic ingredients.

Implications:

  • Pediatricians and dermatologists should consider patch testing for suspected cosmetic-induced dermatitis in children.
  • Early and accurate diagnosis is essential for managing contact dermatitis and preventing future reactions.
  • Further research into the prevalence and specific triggers of childhood contact dermatitis to cosmetic ingredients may be warranted.

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
176
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
224
Allergic Reactions02:06

Allergic Reactions

Overview
34.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
268
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.0K